Significantly lower SCFA levels in feces of AF patients. In animal experiments, supplementation with SCFA prevented upregulation of CAMKII and Ryr2 phosphorylation, disorderly fibrosis, collagen expression, and inflammasome activation in atrial tissue. This evidence concerns the gene RYR2 and atrial fibrillation.